Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eylea
Biotech
Regeneron snaps up eye biotech, snaring science but not staff
No Oxular employees are joining Regeneron, though several will help "short-term with tech transfer and transition work,” a spokesperson said.
Gabrielle Masson
Jan 2, 2025 3:58pm
Innovent's anti-VEGF drug matches Eylea in eye disease trial
Mar 19, 2024 10:36am
Unity preps for Eylea battle following extended midstage test
Apr 24, 2023 10:25am
Kodiak asset matches Regeneron's Eylea in macular edema phase 3
Aug 8, 2022 9:53am
Another rival to Regeneron's Eylea struggles in phase 2
Mar 23, 2022 3:40pm
Kodiak's vision loss drug flops first of 6 phase 3 studies
Feb 23, 2022 10:00am